XML 90 R18.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY
9 Months Ended
Nov. 30, 2019
Equity [Abstract]  
STOCKHOLDERS' EQUITY

NOTE 12 – STOCKHOLDERS’ EQUITY

Employee Stock Purchase Plan

 

On June 7, 2018, our Board of Directors adopted the CalAmp Corp. 2018 Employee Stock Purchase Plan (the “ESPP”), which was approved by our stockholders on July 25, 2018. The ESPP provides for the issuance of 1,750,000 shares of our common stock. The first enrollment under the ESPP Plan commenced in February 2019. There are two enrollment periods each year that commence on February 1st and August 1st and lasts for six months. Stock-based compensation expense related to the ESPP for the three and nine months ended November 30, 2019 was $0.2 million and $0.4 million, respectively.

 

Equity Awards

Stock-based compensation expense is included in the following captions of the condensed consolidated statements of comprehensive income (loss) (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

November 30,

 

 

November 30,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Cost of revenues

 

$

221

 

 

$

251

 

 

$

558

 

 

$

640

 

Research and development

 

 

723

 

 

 

538

 

 

 

1,769

 

 

 

1,323

 

Selling and marketing

 

 

1,058

 

 

 

808

 

 

 

2,709

 

 

 

2,059

 

General and administrative

 

 

1,650

 

 

 

1,344

 

 

 

4,342

 

 

 

4,066

 

 

 

$

3,652

 

 

$

2,941

 

 

$

9,378

 

 

$

8,088

 

 

Changes in our outstanding stock options during the nine months ended November 30, 2019 were as follows (options in thousands):

 

 

 

Number of

Options

 

 

Weighted

Average

Exercise Price

 

 

Weighted average remaining contractual life (years)

 

 

Aggregate intrinsic value

 

Outstanding at February 28, 2019

 

 

1,054

 

 

$

13.44

 

 

 

5.8

 

 

 

 

 

Granted

 

 

171

 

 

 

11.11

 

 

 

 

 

 

 

 

 

Exercised

 

 

(106

)

 

 

2.35

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at November 30, 2019

 

 

1,119

 

 

$

14.14

 

 

 

6.2

 

 

$

1,380

 

Exercisable at November 30, 2019

 

 

681

 

 

$

12.46

 

 

 

4.7

 

 

$

1,380

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in our outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the nine months ended November 30, 2019 were as follows (restricted shares, PSUs and RSUs in thousands):

 

 

 

Number of Restricted

Shares, PSUs

and RSUs

 

 

Weighted

Average Grant

Date Fair Value

 

 

Shares Retained to Cover Statutory Minimum Withholding Taxes

 

Outstanding at February 28, 2019

 

 

1,507

 

 

$

19.77

 

 

 

 

 

Granted

 

 

1,561

 

 

 

11.30

 

 

 

 

 

Vested

 

 

(467

)

 

 

18.91

 

 

 

159

 

Forfeited

 

 

(229

)

 

 

17.30

 

 

 

 

 

Outstanding at November 30, 2019

 

 

2,372

 

 

$

14.58

 

 

 

 

 

 

As of November 30, 2019, there was $31.0 million of total unrecognized stock-based compensation cost related to outstanding nonvested equity awards that is expected to be recognized as an expense over a weighted-average remaining vesting period of 3.4 years.